FDA Approved Medical Products for:

Squamous cell carcinoma of the head and neck

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Cetuximab
Trade Name
(Manufacturer Name)
Erbitux®
(ImClone Systems Incorporated)
Indication
The FDA has approved this product to be used in this manner.
For use in combination with radiation therapy, for the treatment of locally or regionally advanced squamous cell carcinoma of the head and neck (SCCHN) and for use as a single agent for the treatment of patients with recurrent or metastatic SCCHN for whom
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Amifostine
Trade Name
(Manufacturer Name)
Ethyol®
(Medimmune Oncology, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Reduction of the incidence of moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer, where the radiation port includes a substantial portion of the parotid glands.
More Information about this product Drug Information Portal